Race, prostate cancer survival, and membership in a large health maintenance organization

Journal of the National Cancer Institute

Volumn 90, Issue 13, 1998, Pages 986-990

  Robbins, Anthony S ^a   Whittemore, Alice S ^a   Van Den Eeden, Stephen K ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER REGISTRY; CANCER SURVIVAL; CAUSE OF DEATH; DATA ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PROSTATE CANCER; RACE DIFFERENCE;

EID: 0032126913     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.13.986     Document Type: Article

References (21)

1. Cancer facts and figures 1998. Atlanta: American Cancer Society, 1998.
2. Miller BA, Kolonel LN, Berstein L, Young JL Jr, Swanson GM, West D, et al., editors. Racial/ethnic patterns of cancer in the United States 1988-1992. NIH Publ No. 96-4104. Bethesda (MD): National Cancer Institute, 1996.
3. Ries LA, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, editors. SEER cancer statistics review, 1973-1991: tables and graphs. NIH Publ No. 94-2789. Bethesda (MD): National Cancer Institute, 1994.
4. Merrill RM, Brawley OW. Prostate cancer incidence and mortality rates among white and black men. Epidemiology 1997;8:126-31.
5. Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, Severson RK. Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area, 1973 to 1987. Urology 1995;45:93-102.
6. Brawn PN, Johnson EH, Kuhl DL, Riggs MW, Speights VO, Johnson CF 3d, et al. Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer 1993;71:2569-73.
7. Powell IJ, Schwartz K, Hussain M. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology 1995;46:825-30.
8. Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA 1995;274:1599-605.
9. Surveillance, Epidemiology, and End Results (SEER) Program public use CD-ROM (1973-92). Bethesda (MD): National Cancer Institute, July 1995.
10. SEER Program. Comparative staging guide for cancer. Major sites: colon and rectum, lung and bronchus, breast, female genital, prostate gland, urinary bladder. Bethesda (MD): National Institutes of Health, 1993.
11. Beahrs OH, Henson DE, Hutter RV, Myers MH. Prostate. In: Beahrs OH, Henson DE, Hutter RV, Myers MH, editors. Manual for staging cancer. 3rd ed. New York: Lippincott, 1988:177-82.
12. ICD-O. International Classification of Diseases for Oncology. 2nd ed. Geneva: World Health Organization, 1976.
13. SAS System under Microsoft Windows, release 6.12 (TS020). Cary (NC): SAS Institute, Inc., 1996.
14. SAS Technical Report P-243. SAS/STAT Software: The GENMOD procedure, release 6.09. Cary (NC): SAS Institute, Inc., 1993.
15. Kelsey JK, Whittemore AS, Evans AS, Thompson WD. Methods in observational epidemiology. 2nd ed. New York: Oxford University Press, 1996:31-3.
16. Friedman E. Money isn't everything. Nonfinancial barriers to access. JAMA 1994;271:1535-8.
17. Garnick MB. Prostate cancer: screening, diagnosis, and management [published erratum appears in Ann Intern Med 1994;120:698]. Ann Intern Med 1993;118:804-18.
18. Northern California Cancer Center. Prostate cancer survival among San Francisco Bay Area males. Greater Bay Area Cancer Registry Report 1997;7:1-5.
19. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961;6:101-21.
20. Weiss NS. Clinical epidemiology: the study of the outcome of illness. New York: Oxford University Press, 1986:38-40.
21. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993;270:948-54.